Literature DB >> 32448405

Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020.

Simone Bastrup Israelsen1, Klaus Tjelle Kristiansen, Bettina Hindsberger, Charlotte Suppli Ulrik, Ove Andersen, Magnus Jensen, Sten Andersen, Christian Rasmussen, Henrik L Jørgensen, Christian Østergaard, Bjarne Ørskov Lindhardt, Gitte Kronborg, Thomas Benfield.   

Abstract

INTRODUCTION: The first case of coronavirus disease 2019 (COVID-19) disease caused by severe acute respiratory syndrome coronavirus-2 occurred in Denmark on 27 February 2020. On 10 March, the first case of COVID-19 pneumonia was admitted to Hvidovre Hospital.
METHODS: Retrospective case review of individuals 18 years or older who were admitted consecutively to Hvidovre Hospital from 10 March through 23 April 2020.
RESULTS: A total of 175 individuals were admitted with COVID-19 pneumonia. The median age was 71 years, 48.6% were male and 71% had at least one co-morbidity. The most commonly presenting symptoms were dyspnoea, dry cough, and fever. The majority of patients had lymphopenia, elevated liver function tests and C-reactive protein. Nearly two in three presented with multilobar infiltration by chest X-ray. Respiratory failure leading to invasive mechanical ventilation developed in 27 patients (15.4%). By 20 April, 23 of 175 (13.1%) patients remained hospitalised, 43 (24.6%) had died and 109 (62.3%) had been discharged.
CONCLUSIONS: The manifestations of COVID-19 at presentation were similar to those seen in other reports. Our population was older, slightly overrepresented by women and had a high level of co-morbidity. COVID-19 admittance was associated with frequent need of intensive care and mechanical ventilation that was associated with a very high mortality. FUNDING: none. TRIAL REGISTRATION: not relevant. Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Entities:  

Mesh:

Year:  2020        PMID: 32448405

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  23 in total

1.  A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic.

Authors:  Hyung-Jun Kim; Hyeontaek Hwang; Hyunsook Hong; Jae-Joon Yim; Jinwoo Lee
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

2.  Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.

Authors:  Askin Gülsen; Inke R König; Uta Jappe; Daniel Drömann
Journal:  Respirology       Date:  2021-05-06       Impact factor: 6.424

Review 3.  Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.

Authors:  Felix M Reyes; Manuel Hache-Marliere; Dimitris Karamanis; Cesar G Berto; Rodolfo Estrada; Matthew Langston; George Ntaios; Perminder Gulani; Chirag D Shah; Leonidas Palaiodimos
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

4.  The Association of Low Vitamin K Status with Mortality in a Cohort of 138 Hospitalized Patients with COVID-19.

Authors:  Allan Linneberg; Freja Bach Kampmann; Simone Bastrup Israelsen; Liv Rabøl Andersen; Henrik Løvendahl Jørgensen; Håkon Sandholt; Niklas Rye Jørgensen; Sanne Marie Thysen; Thomas Benfield
Journal:  Nutrients       Date:  2021-06-09       Impact factor: 5.717

5.  Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?

Authors:  Stephan Katzenschlager; Alexandra J Zimmer; Claudius Gottschalk; Jürgen Grafeneder; Stephani Schmitz; Sara Kraker; Marlene Ganslmeier; Amelie Muth; Alexander Seitel; Lena Maier-Hein; Andrea Benedetti; Jan Larmann; Markus A Weigand; Sean McGrath; Claudia M Denkinger
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

Review 6.  COVID-19 and COPD.

Authors:  Janice M Leung; Masahiro Niikura; Cheng Wei Tony Yang; Don D Sin
Journal:  Eur Respir J       Date:  2020-08-13       Impact factor: 16.671

7.  Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?

Authors:  Stephan Katzenschlager; Alexandra J Zimmer; Claudius Gottschalk; Juergen Grafeneder; Alexander Seitel; Lena Maier-Hein; Andrea Benedetti; Jan Larmann; Markus A Weigand; Sean McGrath; Claudia M Denkinger
Journal:  medRxiv       Date:  2020-11-12

8.  Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting.

Authors:  Lone Wulff Madsen; Susan Olaf Lindvig; Line Dahlerup Rasmussen; Fredrikke Christie Knudtzen; Christian B Laursen; Anne Øvrehus; Stig Lønberg Nielsen; Isik Somuncu Johansen
Journal:  Int J Infect Dis       Date:  2020-10-12       Impact factor: 3.623

9.  Features of severe COVID-19: A systematic review and meta-analysis.

Authors:  Francesco Del Sole; Alessio Farcomeni; Lorenzo Loffredo; Roberto Carnevale; Danilo Menichelli; Tommasa Vicario; Pasquale Pignatelli; Daniele Pastori
Journal:  Eur J Clin Invest       Date:  2020-08-29       Impact factor: 5.722

10.  Symptomatology of COVID-19 from the otorhinolaryngology perspective: a survey of 223 SARS-CoV-2 RNA-positive patients.

Authors:  Egehan Salepci; Bilge Turk; Safiye Nur Ozcan; Merve Ekici Bektas; Alperen Aybal; Ilyas Dokmetas; Suat Turgut
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.